Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| basal cell | 10 studies | 33% ± 19% | |
| brush cell | 7 studies | 70% ± 13% | |
| ionocyte | 5 studies | 39% ± 12% | |
| epithelial cell | 5 studies | 25% ± 8% | |
| goblet cell | 4 studies | 22% ± 3% | |
| ciliated cell | 3 studies | 25% ± 10% | |
| enteroendocrine cell | 3 studies | 30% ± 6% |
Insufficient scRNA-seq data for expression of RASSF6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 1042.59 | 328 / 328 | 94% | 17.79 | 168 / 178 |
| kidney | 100% | 969.82 | 89 / 89 | 93% | 21.68 | 839 / 901 |
| prostate | 91% | 959.58 | 222 / 245 | 94% | 11.90 | 474 / 502 |
| stomach | 80% | 2355.25 | 286 / 359 | 93% | 16.52 | 267 / 286 |
| intestine | 56% | 1096.66 | 543 / 966 | 92% | 14.09 | 486 / 527 |
| lung | 70% | 177.39 | 404 / 578 | 78% | 10.75 | 905 / 1155 |
| esophagus | 48% | 206.83 | 695 / 1445 | 84% | 18.25 | 153 / 183 |
| bladder | 57% | 1345.38 | 12 / 21 | 74% | 11.13 | 375 / 504 |
| thymus | 97% | 640.96 | 634 / 653 | 22% | 5.51 | 134 / 605 |
| breast | 56% | 363.95 | 257 / 459 | 55% | 6.46 | 619 / 1118 |
| ovary | 69% | 198.76 | 125 / 180 | 6% | 0.29 | 24 / 430 |
| skin | 71% | 428.83 | 1287 / 1809 | 1% | 0.04 | 5 / 472 |
| lymph node | 0% | 0 | 0 / 0 | 66% | 14.74 | 19 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 64% | 5.16 | 29 / 45 |
| uterus | 5% | 25.06 | 9 / 170 | 58% | 8.05 | 265 / 459 |
| liver | 43% | 76.10 | 98 / 226 | 13% | 1.60 | 54 / 406 |
| adrenal gland | 0% | 0.84 | 1 / 258 | 20% | 1.96 | 46 / 230 |
| peripheral blood | 19% | 601.82 | 175 / 929 | 0% | 0 | 0 / 0 |
| spleen | 18% | 30.30 | 44 / 241 | 0% | 0 | 0 / 0 |
| adipose | 8% | 14.52 | 101 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 1% | 2.61 | 17 / 1335 | 0% | 0 | 0 / 0 |
| brain | 1% | 0.84 | 16 / 2642 | 0% | 0.08 | 3 / 705 |
| muscle | 1% | 0.93 | 5 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0006915 | Biological process | apoptotic process |
| GO_0043065 | Biological process | positive regulation of apoptotic process |
| GO_0005515 | Molecular function | protein binding |
| Gene name | RASSF6 |
| Protein name | Ras association domain-containing protein 6 |
| Synonyms | |
| Description | FUNCTION: Involved in the induction of apoptosis, through both caspase-dependent and caspase-independent pathways. May act as a Ras effector protein. May suppress the serum-induced basal levels of NF-kappa-B (By similarity). . |
| Accessions | Q6ZTQ3 ENST00000342081.7 [Q6ZTQ3-1] ENST00000395777.6 [Q6ZTQ3-4] ENST00000307439.10 [Q6ZTQ3-2] ENST00000335049.5 [Q6ZTQ3-3] |
